Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract A022: Neoadjuvant ablative radiation downstages high-risk features and alters immune response in pancreatic cancer

Peter Q. Leung, Eslam A. Elghonaimy, Ahmed M. Elamir, Megan Wachsmann, Song Zhang, Neha Barrows, Rachel von Ebers, Cassandra Hamilton, Grace Josephson, Salwan Al Mutar, Patricio M. Polanco, Nina N. Sanford, Syed M. Ali Kazmi, Matthew R. Porembka, David Hsieh, Adam C. Yopp, Muhammad S. Beg, Herbert J. Zeh, Todd A. Aguilera

Cancer Res (2024) 84 (17_Supplement_2): A022.

https://doi.org/10.1158/1538-7445.PANCREATIC24-A022

Published: 15 September 2024

View articletitled, Abstract A022: Neoadjuvant ablative radiation downstages high-risk features and alters immune response in pancreatic cancer

Journal Articles

HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells

Shan Zhu, Qiuhong Zhang, Xiaofan Sun, Herbert J. Zeh, III, Michael T. Lotze, Rui Kang, Daolin Tang

Cancer Res (2017) 77 (8): 2064–2077.

https://doi.org/10.1158/0008-5472.CAN-16-1979

Published: 13 April 2017

View articletitled, HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells

Includes: Supplementary data

Journal Articles

Abstract 3009: Targeting G-protein coupled receptor-related pathway in mucinous tumors

Ashok K. Dilly, Yong J. Lee, Herbert J. Zeh, David L. Bartlett, Mohammad Haroon A. Choudry.

Cancer Res (2016) 76 (14_Supplement): 3009.

https://doi.org/10.1158/1538-7445.AM2016-3009

Published: 15 July 2016

View articletitled, Abstract 3009: Targeting G-protein coupled receptor-related pathway in mucinous tumors

Journal Articles

Abstract B96: The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.

Rui Kang, Daolin Tang, Nicole E. Schapiro, Michael T. Lotze, Herbert J. Zeh

Cancer Res (2012) 72 (14_Supplement): B96.

https://doi.org/10.1158/1538-7445.PANCA2012-B96

Published: 03 April 2014

View articletitled, Abstract B96: The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.

Journal Articles

NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

Ravikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, Herbert J. Zeh, Amer H. Zureikat, Daniel Normolle, The Minh Luong, Todd A. Reinhart, David L. Bartlett, Pawel Kalinski

Cancer Res (2012) 72 (15): 3735–3743.

https://doi.org/10.1158/0008-5472.CAN-11-4136

Published: 31 July 2012

View articletitled, NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

Includes: Supplementary data

Journal Articles

Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression

Xiaoyan Liang, Michael E. De Vera, William J. Buchser, Antonio Romo de Vivar Chavez, Patricia Loughran, Donna Beer Stolz, Per Basse, Tao Wang, Bennett Van Houten, Herbert J. Zeh, III, Michael T. Lotze

Cancer Res (2012) 72 (11): 2791–2801.

https://doi.org/10.1158/0008-5472.CAN-12-0320

Published: 31 May 2012

View articletitled, Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression

Includes: Supplementary data

Journal Articles

p53/HMGB1 Complexes Regulate Autophagy and Apoptosis

Kristen M. Livesey, Rui Kang, Philip Vernon, William Buchser, Patricia Loughran, Simon C. Watkins, Lin Zhang, James J. Manfredi, Herbert J. Zeh, III, Luyuan Li, Michael T. Lotze, Daolin Tang

Cancer Res (2012) 72 (8): 1996–2005.

https://doi.org/10.1158/0008-5472.CAN-11-2291

Published: 16 April 2012

View articletitled, p53/HMGB1 Complexes Regulate Autophagy and Apoptosis

Includes: Supplementary data

Journal Articles

Abstract 5253: MEK-ERK pathway inhibition reduces mucin production in a murine xenograft model of pseudomyxoma peritonei

Haroon A. Choudry, Arun Mavanur, Mark E. O'Malley, Zong Sheng Guo, Herbert J. Zeh, David L. Bartlett

Cancer Res (2012) 72 (8_Supplement): 5253.

https://doi.org/10.1158/1538-7445.AM2012-5253

Published: 15 April 2012

View articletitled, Abstract 5253: MEK-ERK pathway inhibition reduces mucin production in a murine xenograft model of pseudomyxoma peritonei

Journal Articles

Abstract 4854: Inhibition of high-mobility group box 1 protein (HMGB1) release sensitizes cancer cells to chemotherapy

Daolin Tang, Rui Kang, Herbert J. Zeh, Michael T. Lotze

Cancer Res (2010) 70 (8_Supplement): 4854.

https://doi.org/10.1158/1538-7445.AM10-4854

Published: 15 April 2010

View articletitled, Abstract 4854: Inhibition of high-mobility group box 1 protein (HMGB1) release sensitizes cancer cells to chemotherapy

Journal Articles

Abstract 4674: Receptor for advanced glycation endproducts (RAGE) regulates ß-catenin function and chemosensitivity in pancreatic cancer cells

Rui Kang, Daolin Tang, Michael T. Lotze, Herbert J. Zeh

Cancer Res (2010) 70 (8_Supplement): 4674.

https://doi.org/10.1158/1538-7445.AM10-4674

Published: 15 April 2010

View articletitled, Abstract 4674: Receptor for advanced glycation endproducts (RAGE) regulates ß-catenin function and chemosensitivity in pancreatic cancer cells

Journal Articles

The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2

Z. Sheng Guo, Arpana Naik, Mark E. O'Malley, Petar Popovic, Richard Demarco, Yun Hu, Xiaoyu Yin, Shuting Yang, Herbert J. Zeh, Bernard Moss, Michael T. Lotze, David L. Bartlett

Cancer Res (2005) 65 (21): 9991–9998.

https://doi.org/10.1158/0008-5472.CAN-05-1630

Published: 01 November 2005

View articletitled, The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2

Journal Articles

HMGB1 as a marker of tumor development in mice with spontaneous hepatoma and implanted MC38 adenocarcinoma

Xiang Da Dong, Petar Popovic, Michael T. Lotze, Kevin Stavely-O’carroll, Sri Chalikonda, David L. Bartlett, Herbert J. Zeh III

Cancer Res (2005) 65 (9_Supplement): 1109.

Published: 01 May 2005

View articletitled, HMGB1 as a marker of tumor development in mice with spontaneous hepatoma and implanted MC38 adenocarcinoma

Journal Articles

Serum SELDI-TOF-MS expression profiling and Luminex Xmap® marker panel classification analysis of pancreatic cancer patients and controls.

Herbert J. Zeh, III, David E. Malehorn, Jill M. Siegfried, David L. Bartlett, Michael T. Lotze, Stephen E. Winikoff, Anna Lokshin, William L. Bigbee

Cancer Res (2004) 64 (7_Supplement): 821–822.

Published: 01 April 2004

View articletitled, Serum SELDI-TOF-MS expression profiling and Luminex Xmap® marker panel classification analysis of pancreatic cancer patients and controls.

Journal Articles

Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo

Hideaki Tahara, Herbert J. Zeh, III, Walter J. Storkus, Itzhak Pappo, Simon C. Watkins, Ueli Gubler, Stanley F. Wolf, Paul D. Robbins, Michael T. Lotze

Cancer Res (1994) 54 (1): 182–189.

Published: 01 January 1994

View articletitled, Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract A022: Neoadjuvant ablative radiation downstages high-risk features and alters immune response in pancreatic cancer

HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells

Abstract 3009: Targeting G-protein coupled receptor-related pathway in mucinous tumors

Abstract B96: The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.

NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression

p53/HMGB1 Complexes Regulate Autophagy and Apoptosis

Abstract 5253: MEK-ERK pathway inhibition reduces mucin production in a murine xenograft model of pseudomyxoma peritonei

Abstract 4854: Inhibition of high-mobility group box 1 protein (HMGB1) release sensitizes cancer cells to chemotherapy

Abstract 4674: Receptor for advanced glycation endproducts (RAGE) regulates ß-catenin function and chemosensitivity in pancreatic cancer cells

The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2

HMGB1 as a marker of tumor development in mice with spontaneous hepatoma and implanted MC38 adenocarcinoma

Serum SELDI-TOF-MS expression profiling and Luminex Xmap® marker panel classification analysis of pancreatic cancer patients and controls.

Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only